US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

LB Pharmaceuticals

36.99

-0.2900-0.78%

Post-market: 36.990.00000.00%19:30 EDT

Volume:388.89K

Turnover:14.44M

Market Cap:1.19B

PE:-12.38

High:38.82

Open:37.72

Low:36.75

Close:37.28

52wk High:50.16

52wk Low:14.32

Shares:32.26M

Float Shares:21.62M

Volume Ratio:0.82

T/O Rate:1.80%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-2.9880

EPS(LYR):-3.1329

ROE:-50.00%

ROA:-29.98%

PB:3.59

PE(LYR):-11.81

Loading ...

Overview Company News Filings

Needham Initiates LB Pharmaceuticals at Buy With $68 Price Target

MT Newswires Live

LB Pharmaceuticals Initiated at Buy by Needham

LB Pharmaceuticals initiated with a Buy at Needham

Analyst Initiates Buy Rating on LB-102 for De-Risked Antipsychotic Profile, Multi-Indication Potential and Strong Long-Term Revenue Outlook

Lb Pharmaceuticals Inc : Needham Initiates Coverage with Buy Rating; Target Price $68

THOMSON REUTERS

Lb Pharmaceuticals Inc Files for Mixed Shelf; Size not Disclosed - SEC Filing

THOMSON REUTERS

LB Pharmaceuticals’ Chief Medical Officer Susan Gani Kozauer Files Initial Beneficial Ownership Statement (Form 3)

Lb Pharmaceuticals Appoints Susan G. Kozauer, M.d. as Chief Medical Officer

THOMSON REUTERS

Press Release: LB Pharmaceuticals Appoints Susan G. Kozauer, M.D. as Chief Medical Officer

LB Pharmaceuticals CFO Joseph M. Miller Files Initial Beneficial Ownership Statement

LB Pharmaceuticals to Participate in Upcoming September Investor Events

LB Pharmaceuticals Names Joseph Miller CFO

MT Newswires Live

Lb Pharmaceuticals Appoints Joseph Miller as Chief Financial Officer

THOMSON REUTERS

Press Release: LB Pharmaceuticals Appoints Joseph Miller as Chief Financial Officer

LB Pharmaceuticals price target raised to $69 from $45 at Clear Street

Lb Pharmaceuticals Inc : Stifel Raises Target Price to $53 from $40

THOMSON REUTERS

Craig-Hallum Remains a Buy on LB Pharmaceuticals, Inc. (LBRX)

U.S. Research Roundup-Cardinal Health, Lumentum Holdings, Public Storage

Lb Pharmaceuticals Inc : Leerink Partners Raises Target Price to $55 from $40

THOMSON REUTERS

Sellas Life Sciences Q2 Net Loss Widens on Higher Expenses

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigershowtime.com/stock/LBRX/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"LBRX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LBRX\",,,,,undefined,":{"symbol":"LBRX","market":"US","secType":"STK","nameCN":"LB Pharmaceuticals","latestPrice":36.99,"timestamp":1790971200000,"preClose":37.28,"halted":0,"volume":388885,"hourTrading":{"tag":"盘后","latestPrice":36.99,"preClose":36.99,"latestTime":"19:30 EDT","volume":2661,"amount":98430.39,"timestamp":1790983804912,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.007778969957081522,"floatShares":21621800,"shares":32259175,"eps":-2.988,"marketStatus":"Closed","change":-0.29,"latestTime":"10-02 16:00:00 EDT","open":37.72,"high":38.815,"low":36.75,"amount":14443570.007299999,"amplitude":0.055392,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.988,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791187200000},"marketStatusCode":5,"adr":0,"listingDate":1757563200000,"exchange":"NASDAQ","adjPreClose":37.28,"postHourTrading":{"tag":"盘后","latestPrice":36.99,"preClose":36.99,"latestTime":"19:30 EDT","volume":2661,"amount":98430.39,"timestamp":1790983804912,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.822858,"impliedVol":1.0903,"impliedVolPercentile":0.9432},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LBRX\",,,,,undefined,":{"symbol":"LBRX","floatShares":21621800,"roa":"-29.98%","roe":"-50.00%","lyrEps":-3.132945,"volumeRatio":0.822858,"shares":32259175,"dividePrice":0,"high":38.815,"amplitude":0.055392,"preClose":37.28,"low":36.75,"week52Low":14.3166,"pbRate":"3.59","week52High":50.16,"institutionHeld":0,"latestPrice":36.99,"eps":-2.988,"divideRate":0,"volume":388885,"delay":0,"ttmEps":-2.988,"open":37.72,"prevYearClose":22.26,"prevWeekClose":37.33,"prevMonthClose":38.38,"prevQuarterClose":38.38,"fiveDayClose":37.33,"twentyDayClose":47.52,"sixtyDayClose":33.74},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LBRX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-11","symbol":"LBRX","fiscalQuarterEnding":"2026/06","expectedEps":-0.84,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1786420800000,"reportTimeType":"pre","actualEps":-1.71},{"market":"US","date":"2026-05-12","symbol":"LBRX","fiscalQuarterEnding":"2026/03","expectedEps":-0.75,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1778558400000,"reportTimeType":"post","actualEps":-0.67},{"market":"US","date":"2026-03-26","symbol":"LBRX","fiscalQuarterEnding":"2025/12","expectedEps":-0.45,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1774497600000,"reportTimeType":"post","actualEps":-0.45}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LBRX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LBRX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3,"buy":0.7,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.7,"analysts":10,"updateTime":1784606400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/LBRX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"LBRX","date":"2026-10-01","current":-12.379518,"percent":0.829545,"low":-37.407457,"twenty":-31.692493,"median":-23.786169,"eighty":-16.200178,"high":-0.410019,"avg":-23.53712,"sd":7.556968,"marketCap":1238107136},"quantilePoints":[{"date":"2025-09-12","current":-13.187639,"twenty":-10.632115,"median":-6.798829,"eighty":-2.965543,"marketCap":388099031},{"date":"2025-09-19","current":-12.217088,"twenty":-12.798201,"median":-12.438246,"eighty":-12.070666,"marketCap":359536683},{"date":"2025-09-26","current":-11.40109,"twenty":-12.682283,"median":-12.163705,"eighty":-11.408716,"marketCap":335522685},{"date":"2025-10-03","current":-11.790024,"twenty":-12.394014,"median":-12.03406,"eighty":-11.475827,"marketCap":346968609},{"date":"2025-10-10","current":-11.927294,"twenty":-12.217088,"median":-11.973051,"eighty":-11.471251,"marketCap":351008347},{"date":"2025-10-17","current":-12.506882,"twenty":-12.401641,"median":-12.018808,"eighty":-11.491079,"marketCap":368065019},{"date":"2025-10-24","current":-12.079817,"twenty":-12.247593,"median":-12.026434,"eighty":-11.561239,"marketCap":355496945},{"date":"2025-10-31","current":-12.415368,"twenty":-12.43367,"median":-12.041687,"eighty":-11.652753,"marketCap":365371860},{"date":"2025-11-07","current":-18.511527,"twenty":-12.493155,"median":-12.14464,"eighty":-11.774771,"marketCap":348090759},{"date":"2025-11-14","current":-20.046619,"twenty":-12.715838,"median":-12.201836,"eighty":-11.777822,"marketCap":376956619},{"date":"2025-11-21","current":-21.244034,"twenty":-16.587413,"median":-12.217088,"eighty":-11.811377,"marketCap":399472820},{"date":"2025-11-28","current":-23.934856,"twenty":-18.511527,"median":-12.278098,"eighty":-11.89679,"marketCap":450071024},{"date":"2025-12-05","current":-25.899155,"twenty":-20.625145,"median":-12.354359,"eighty":-11.912042,"marketCap":487007713},{"date":"2025-12-12","current":-27.217658,"twenty":-21.714928,"median":-12.472564,"eighty":-11.927294,"marketCap":511800833},{"date":"2025-12-19","current":-26.50459,"twenty":-23.934856,"median":-12.598395,"eighty":-11.934921,"marketCap":498392309},{"date":"2025-12-26","current":-29.599034,"twenty":-25.317938,"median":-12.735666,"eighty":-11.971526,"marketCap":556580244},{"date":"2026-01-02","current":-29.948841,"twenty":-26.033696,"median":-12.811928,"eighty":-12.003556,"marketCap":563158010},{"date":"2026-01-09","current":-27.984542,"twenty":-26.736001,"median":-17.717835,"eighty":-12.027959,"marketCap":526221321},{"date":"2026-01-16","current":-28.76488,"twenty":-26.943194,"median":-18.511527,"eighty":-12.038636,"marketCap":540894800},{"date":"2026-01-23","current":-31.724783,"twenty":-27.597063,"median":-20.046619,"eighty":-12.056939,"marketCap":596552825},{"date":"2026-01-30","current":-28.482344,"twenty":-28.30475,"median":-20.93459,"eighty":-12.092019,"marketCap":535581989},{"date":"2026-02-06","current":-32.101498,"twenty":-28.673392,"median":-21.418938,"eighty":-12.137776,"marketCap":603636573},{"date":"2026-02-13","current":-32.760749,"twenty":-28.899421,"median":-22.367452,"eighty":-12.188109,"marketCap":616033133},{"date":"2026-02-20","current":-32.558938,"twenty":-29.179266,"median":-23.692682,"eighty":-12.201836,"marketCap":612238268},{"date":"2026-02-27","current":-32.5993,"twenty":-29.599034,"median":-24.876643,"eighty":-12.203361,"marketCap":612997241},{"date":"2026-03-06","current":-31.684421,"twenty":-30.30403,"median":-25.616619,"eighty":-12.210987,"marketCap":595793852},{"date":"2026-03-13","current":-33.554542,"twenty":-31.627914,"median":-25.899155,"eighty":-12.217088,"marketCap":630959603},{"date":"2026-03-20","current":-32.276402,"twenty":-31.988483,"median":-26.370049,"eighty":-12.224714,"marketCap":606925456},{"date":"2026-03-27","current":-24.621582,"twenty":-31.988483,"median":-26.625677,"eighty":-12.26437,"marketCap":620586972},{"date":"2026-04-02","current":-24.902627,"twenty":-31.966957,"median":-26.235508,"eighty":-12.300976,"marketCap":627670720},{"date":"2026-04-10","current":-26.388153,"twenty":-31.886233,"median":-26.156251,"eighty":-12.33148,"marketCap":665113391},{"date":"2026-04-17","current":-28.385582,"twenty":-31.84587,"median":-26.235508,"eighty":-12.354359,"marketCap":715458604},{"date":"2026-04-24","current":-35.011617,"twenty":-31.993865,"median":-26.565134,"eighty":-12.415368,"marketCap":882467800},{"date":"2026-05-01","current":-36.076352,"twenty":-32.168769,"median":-26.669198,"eighty":-12.438246,"marketCap":909304449},{"date":"2026-05-08","current":-36.38353,"twenty":-32.30331,"median":-26.814034,"eighty":-12.506882,"marketCap":917046871},{"date":"2026-05-15","current":-23.123601,"twenty":-32.316764,"median":-26.760218,"eighty":-12.583143,"marketCap":900733639},{"date":"2026-05-22","current":-20.613207,"twenty":-32.30331,"median":-26.667619,"eighty":-12.598395,"marketCap":802946256},{"date":"2026-05-29","current":-20.2672,"twenty":-32.30331,"median":-26.565134,"eighty":-12.6289,"marketCap":789468229},{"date":"2026-06-05","current":-21.275774,"twenty":-32.281784,"median":-26.235508,"eighty":-12.715838,"marketCap":828755242},{"date":"2026-06-12","current":-21.010748,"twenty":-32.254875,"median":-25.973152,"eighty":-12.741767,"marketCap":818431648},{"date":"2026-06-18","current":-22.122388,"twenty":-32.201059,"median":-25.758446,"eighty":-12.784474,"marketCap":861733392},{"date":"2026-06-26","current":-22.821765,"twenty":-32.168769,"median":-25.603165,"eighty":-13.037355,"marketCap":888976212},{"date":"2026-07-02","current":-23.476971,"twenty":-32.141861,"median":-25.394457,"eighty":-14.887526,"marketCap":914498432},{"date":"2026-07-10","current":-24.838915,"twenty":-32.079972,"median":-25.197689,"eighty":-17.661739,"marketCap":967550238},{"date":"2026-07-17","current":-22.519929,"twenty":-32.026155,"median":-24.876643,"eighty":-18.127213,"marketCap":877218784},{"date":"2026-07-24","current":-25.486758,"twenty":-31.993865,"median":-24.857779,"eighty":-18.396949,"marketCap":992785692},{"date":"2026-07-31","current":-30.110006,"twenty":-31.988483,"median":-25.029051,"eighty":-18.623718,"marketCap":1172875066},{"date":"2026-08-07","current":-35.46944,"twenty":-32.036919,"median":-25.243817,"eighty":-19.236335,"marketCap":1381641093},{"date":"2026-08-14","current":-16.667021,"twenty":-32.036919,"median":-25.197689,"eighty":-18.062763,"marketCap":1428113677},{"date":"2026-08-21","current":-17.781418,"twenty":-31.993865,"median":-24.876643,"eighty":-17.822455,"marketCap":1523600835},{"date":"2026-08-28","current":-18.029899,"twenty":-31.988483,"median":-24.686825,"eighty":-17.939919,"marketCap":1544891890},{"date":"2026-09-04","current":-17.890599,"twenty":-31.950812,"median":-24.595973,"eighty":-17.81229,"marketCap":1532955996},{"date":"2026-09-11","current":-17.412462,"twenty":-31.886233,"median":-24.257328,"eighty":-17.792713,"marketCap":1491986843},{"date":"2026-09-18","current":-15.865106,"twenty":-31.84587,"median":-23.934856,"eighty":-17.412462,"marketCap":1359401634},{"date":"2026-09-25","current":-14.231158,"twenty":-31.724783,"median":-23.892916,"eighty":-16.881618,"marketCap":1219396815},{"date":"2026-10-01","current":-14.44952,"twenty":-31.692493,"median":-23.786169,"eighty":-16.200178,"marketCap":1238107136}],"updateTime":1790993219468},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LBRX\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2672715536","title":"Needham Initiates LB Pharmaceuticals at Buy With $68 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2672715536","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672715536?lang=en_us&edition=fundamental","pubTime":"2026-10-02 17:48","pubTimestamp":1790934506,"startTime":"0","endTime":"0","summary":"LB Pharmaceuticals (LBRX)has an average rating of buy and mean price target of $58.56, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major b","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LBRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672132107","title":"LB Pharmaceuticals Initiated at Buy by Needham","url":"https://stock-news.laohu8.com/highlight/detail?id=2672132107","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672132107?lang=en_us&edition=fundamental","pubTime":"2026-10-02 17:29","pubTimestamp":1790933340,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/LBRX/analyst-ratings","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","LBRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672713863","title":"LB Pharmaceuticals initiated with a Buy at Needham","url":"https://stock-news.laohu8.com/highlight/detail?id=2672713863","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672713863?lang=en_us&edition=fundamental","pubTime":"2026-10-02 16:55","pubTimestamp":1790931308,"startTime":"0","endTime":"0","summary":"Needham initiated coverage of LB Pharmaceuticals (LBRX) with a Buy rating and $68 price target The company’s LB-102 is an improved version of amisu...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/lb-pharmaceuticals-initiated-with-a-buy-at-needham-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/lb-pharmaceuticals-initiated-with-a-buy-at-needham-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LBRX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672718168","title":"Analyst Initiates Buy Rating on LB-102 for De-Risked Antipsychotic Profile, Multi-Indication Potential and Strong Long-Term Revenue Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2672718168","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672718168?lang=en_us&edition=fundamental","pubTime":"2026-10-02 16:35","pubTimestamp":1790930121,"startTime":"0","endTime":"0","summary":"LB Pharmaceuticals, Inc. (LBRX) has received a new Buy rating, initiated by Needham analyst, Ami Fadia. Ami Fadia has given his Buy rating due to a...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/analyst-initiates-buy-rating-on-lb-102-for-de-risked-antipsychotic-profile-multi-indication-potential-and-strong-long-term-revenue-outlook-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/analyst-initiates-buy-rating-on-lb-102-for-de-risked-antipsychotic-profile-multi-indication-potential-and-strong-long-term-revenue-outlook-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LBRX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672718328","title":"Lb Pharmaceuticals Inc : Needham Initiates Coverage with Buy Rating; Target Price $68","url":"https://stock-news.laohu8.com/highlight/detail?id=2672718328","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672718328?lang=en_us&edition=fundamental","pubTime":"2026-10-02 16:25","pubTimestamp":1790929528,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nFWN45O0N5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LBRX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672649167","title":"Lb Pharmaceuticals Inc Files for Mixed Shelf; Size not Disclosed - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2672649167","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672649167?lang=en_us&edition=fundamental","pubTime":"2026-10-02 04:06","pubTimestamp":1790885213,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nFWN45N151:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","LBRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670418185","title":"LB Pharmaceuticals’ Chief Medical Officer Susan Gani Kozauer Files Initial Beneficial Ownership Statement (Form 3)","url":"https://stock-news.laohu8.com/highlight/detail?id=2670418185","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670418185?lang=en_us&edition=fundamental","pubTime":"2026-09-25 04:27","pubTimestamp":1790281648,"startTime":"0","endTime":"0","summary":"LB Pharmaceuticals’ Chief Medical Officer Susan Gani Kozauer files initial beneficial ownership statement (Form 3)LB Pharmaceuticals filed a Form 3 naming Susan Gani Kozauer as chief medical officer, ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nNDL9n9GmP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","LBRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667644444","title":"Lb Pharmaceuticals Appoints Susan G. Kozauer, M.d. as Chief Medical Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2667644444","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667644444?lang=en_us&edition=fundamental","pubTime":"2026-09-15 20:00","pubTimestamp":1789473608,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nTUA6SQT0T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","LBRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667176644","title":"Press Release: LB Pharmaceuticals Appoints Susan G. Kozauer, M.D. as Chief Medical Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2667176644","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667176644?lang=en_us&edition=fundamental","pubTime":"2026-09-15 20:00","pubTimestamp":1789473600,"startTime":"0","endTime":"0","summary":"NEW YORK, Sept. 15, 2026 (GLOBE NEWSWIRE) -- LB Pharmaceuticals Inc (\"LB Pharmaceuticals\" or the \"Company\") (Nasdaq: LBRX), a neuromedicines company dedicated to developing and commercializing high-im","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LBRX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667695896","title":"LB Pharmaceuticals CFO Joseph M. Miller Files Initial Beneficial Ownership Statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2667695896","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667695896?lang=en_us&edition=fundamental","pubTime":"2026-09-15 04:16","pubTimestamp":1789416965,"startTime":"0","endTime":"0","summary":"LB Pharmaceuticals CFO Joseph M. Miller files initial beneficial ownership statementLB Pharmaceuticals named Joseph M. Miller as chief financial officer in an initial Form 3 insider filing dated 09/02","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nNDL7T2zSC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LBRX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664801118","title":"LB Pharmaceuticals to Participate in Upcoming September Investor Events","url":"https://stock-news.laohu8.com/highlight/detail?id=2664801118","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664801118?lang=en_us&edition=fundamental","pubTime":"2026-09-04 04:05","pubTimestamp":1788465900,"startTime":"0","endTime":"0","summary":"NEW YORK, Sept.  03, 2026 (GLOBE NEWSWIRE) -- LB Pharmaceuticals Inc (“LB Pharmaceuticals” or the “Company”) (Nasdaq: LBRX), a neuromedicines company dedicated to developing and commercializing high-i","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/03/3356251/0/en/lb-pharmaceuticals-to-participate-in-upcoming-september-investor-events.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","LBRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664874706","title":"LB Pharmaceuticals Names Joseph Miller CFO","url":"https://stock-news.laohu8.com/highlight/detail?id=2664874706","media":"MT Newswires Live","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664874706?lang=en_us&edition=fundamental","pubTime":"2026-09-03 20:38","pubTimestamp":1788439125,"startTime":"0","endTime":"0","summary":"LB Pharmaceuticals (LBRX) said Thursday it named Joseph Miller its chief financial officer.Miller was previously Aurinia Pharmaceuticals' (AUPH) CFO, LB Pharmaceuticals said.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","LBRX","BK4007","CFO","BK4149","MLR","AUPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664871485","title":"Lb Pharmaceuticals Appoints Joseph Miller as Chief Financial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2664871485","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664871485?lang=en_us&edition=fundamental","pubTime":"2026-09-03 20:00","pubTimestamp":1788436803,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nTUA9T67BV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","LBRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664871172","title":"Press Release: LB Pharmaceuticals Appoints Joseph Miller as Chief Financial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2664871172","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664871172?lang=en_us&edition=fundamental","pubTime":"2026-09-03 20:00","pubTimestamp":1788436800,"startTime":"0","endTime":"0","summary":"NEW YORK, Sept. 03, 2026 (GLOBE NEWSWIRE) -- LB Pharmaceuticals Inc (\"LB Pharmaceuticals\" or the \"Company\") (Nasdaq: LBRX), a neuromedicines company dedicated to developing and commercializing high-im","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LBRX","BK4007","BK4149","MLR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661323298","title":"LB Pharmaceuticals price target raised to $69 from $45 at Clear Street","url":"https://stock-news.laohu8.com/highlight/detail?id=2661323298","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661323298?lang=en_us&edition=fundamental","pubTime":"2026-08-21 04:15","pubTimestamp":1787256916,"startTime":"0","endTime":"0","summary":"Clear Street analyst Kaveri Pohlman raised the firm’s price target on LB Pharmaceuticals (LBRX) to $69 from $45 and keeps a Buy rating on the share...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/lb-pharmaceuticals-price-target-raised-to-69-from-45-at-clear-street-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/lb-pharmaceuticals-price-target-raised-to-69-from-45-at-clear-street-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LB","LBRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659598441","title":"Lb Pharmaceuticals Inc : Stifel Raises Target Price to $53 from $40","url":"https://stock-news.laohu8.com/highlight/detail?id=2659598441","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659598441?lang=en_us&edition=fundamental","pubTime":"2026-08-13 19:20","pubTimestamp":1786620019,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nFWN44A1BM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","LBRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658990840","title":"Craig-Hallum Remains a Buy on LB Pharmaceuticals, Inc. (LBRX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2658990840","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658990840?lang=en_us&edition=fundamental","pubTime":"2026-08-12 21:36","pubTimestamp":1786541770,"startTime":"0","endTime":"0","summary":"Craig-Hallum analyst Adam Vogel maintained a Buy rating on LB Pharmaceuticals, Inc. today and set a price target of $45.00. Vogel covers the Health...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/craig-hallum-remains-a-buy-on-lb-pharmaceuticals-inc-lbrx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/craig-hallum-remains-a-buy-on-lb-pharmaceuticals-inc-lbrx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4233","LB","BK4007","LBRX","BK4213"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658276289","title":"U.S. Research Roundup-Cardinal Health, Lumentum Holdings, Public Storage","url":"https://stock-news.laohu8.com/highlight/detail?id=2658276289","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658276289?lang=en_us&edition=fundamental","pubTime":"2026-08-12 16:07","pubTimestamp":1786522040,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-Cardinal Health, Lumentum Holdings, Public StorageAug 12 (Reuters)-Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, inclu","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nL4N4490GI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BLCK","EXR","NTRA","HLIO","CRWV","ACM","LEGN","RPD","CUBE","PSA","SR","MDLN","CVS","HD","MAA","TXG","JBIO","SGMT","CRCL","NEM","TGT","CANC","LAZR","LENZ","COAG","EGGY","ARKG","GDX","BCAX","ACVA","FXU","LOW","LPTH","PNW","LBRX","CAH","AMBQ","MNST","CAVA","RSPS","BBIO","JAZZ","LITE","FLUT","ANF","REZ","ODDZ","MRCY","AUAU","GAP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658928106","title":"Lb Pharmaceuticals Inc : Leerink Partners Raises Target Price to $55 from $40","url":"https://stock-news.laohu8.com/highlight/detail?id=2658928106","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658928106?lang=en_us&edition=fundamental","pubTime":"2026-08-12 11:37","pubTimestamp":1786505856,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nFWN4481AY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","LBRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658438799","title":"Sellas Life Sciences Q2 Net Loss Widens on Higher Expenses","url":"https://stock-news.laohu8.com/highlight/detail?id=2658438799","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658438799?lang=en_us&edition=fundamental","pubTime":"2026-08-12 04:13","pubTimestamp":1786479212,"startTime":"0","endTime":"0","summary":"SELLAS Life Sciences Q2 net loss widens on higher expensesOverviewUS biopharma firm's Q2 net loss widened yr/yr as operating expenses increasedCompany ended Q2 with $138.3 mln in cash and cash equival","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nL1N4480YN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SLS","LBRX","IMNN","BK4007","BK4139","OLMA","BK4505"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":1,"totalSize":82,"code":"91000000","status":"200"}]}}